These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 18304647

  • 1. Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics?
    Abraham PF, Calabrese JR.
    J Affect Disord; 2008 Nov; 111(1):21-30. PubMed ID: 18304647
    [Abstract] [Full Text] [Related]

  • 2. Recent trends in the pharmacotherapy of personality disorders.
    Markovitz PJ.
    J Pers Disord; 2004 Feb; 18(1):90-101. PubMed ID: 15061346
    [Abstract] [Full Text] [Related]

  • 3. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials.
    Lieb K, Völlm B, Rücker G, Timmer A, Stoffers JM.
    Br J Psychiatry; 2010 Jan; 196(1):4-12. PubMed ID: 20044651
    [Abstract] [Full Text] [Related]

  • 4. Psychopharmacology of borderline personality disorder.
    Raj YP.
    Curr Psychiatry Rep; 2004 Jun; 6(3):225-31. PubMed ID: 15142476
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacotherapy effectiveness for some symptoms of borderline personality disorder].
    Benjaminsen S.
    Ugeskr Laeger; 2014 Sep 01; 176(36):. PubMed ID: 25293847
    [Abstract] [Full Text] [Related]

  • 6. Pharmacotherapy of borderline personality disorder.
    Hirschfeld RM.
    J Clin Psychiatry; 1997 Sep 01; 58 Suppl 14():48-52; discussion 53. PubMed ID: 9418746
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological interventions for borderline personality disorder.
    Stoffers J, Völlm BA, Rücker G, Timmer A, Huband N, Lieb K.
    Cochrane Database Syst Rev; 2010 Jun 16; (6):CD005653. PubMed ID: 20556762
    [Abstract] [Full Text] [Related]

  • 8. Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials.
    Vita A, De Peri L, Sacchetti E.
    J Clin Psychopharmacol; 2011 Oct 16; 31(5):613-24. PubMed ID: 21869691
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis.
    Gartlehner G, Crotty K, Kennedy S, Edlund MJ, Ali R, Siddiqui M, Fortman R, Wines R, Persad E, Viswanathan M.
    CNS Drugs; 2021 Oct 16; 35(10):1053-1067. PubMed ID: 34495494
    [Abstract] [Full Text] [Related]

  • 10. State of the art in the pharmacologic treatment of borderline personality disorder.
    Feurino L, Silk KR.
    Curr Psychiatry Rep; 2011 Feb 16; 13(1):69-75. PubMed ID: 21140245
    [Abstract] [Full Text] [Related]

  • 11. Pharmacotherapy of post-traumatic stress disorder.
    Ravindran LN, Stein MB.
    Curr Top Behav Neurosci; 2010 Feb 16; 2():505-25. PubMed ID: 21309124
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of pharmacotherapies for borderline personality disorder.
    Bellino S, Paradiso E, Bogetto F.
    CNS Drugs; 2008 Feb 16; 22(8):671-92. PubMed ID: 18601305
    [Abstract] [Full Text] [Related]

  • 13. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.
    Asnis GM, Kohn SR, Henderson M, Brown NL.
    Drugs; 2004 Feb 16; 64(4):383-404. PubMed ID: 14969574
    [Abstract] [Full Text] [Related]

  • 14. Medications in the treatment of borderline personality disorder 2006.
    Mercer D.
    Curr Psychiatry Rep; 2007 Feb 16; 9(1):53-62. PubMed ID: 17257515
    [Abstract] [Full Text] [Related]

  • 15. [Drug therapy of patients with emotionally unstable personality].
    Nissen T.
    Tidsskr Nor Laegeforen; 2000 Aug 10; 120(18):2135-41. PubMed ID: 11006733
    [Abstract] [Full Text] [Related]

  • 16. Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder.
    Hollander E.
    J Clin Psychiatry; 1999 Aug 10; 60 Suppl 15():38-44. PubMed ID: 10418814
    [Abstract] [Full Text] [Related]

  • 17. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.
    Mercer D, Douglass AB, Links PS.
    J Pers Disord; 2009 Apr 10; 23(2):156-74. PubMed ID: 19379093
    [Abstract] [Full Text] [Related]

  • 18. Clinical outcome of psychopharmacologic treatment of borderline and schizotypal personality disordered subjects.
    Coccaro EF.
    J Clin Psychiatry; 1998 Apr 10; 59 Suppl 1():30-5; discussion 36-7. PubMed ID: 9448667
    [Abstract] [Full Text] [Related]

  • 19. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.
    Encephale; 2004 Apr 10; 30(5):417-24. PubMed ID: 15627046
    [Abstract] [Full Text] [Related]

  • 20. Personality trait dimensions and the pharmacological treatment of borderline personality disorder.
    Saunders EF, Silk KR.
    J Clin Psychopharmacol; 2009 Oct 10; 29(5):461-7. PubMed ID: 19745646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.